Cho, Christina http://orcid.org/0000-0002-7964-3011
Maloy, Molly A.
Devlin, Sean M.
Aras, Omer
Dauer, Lawrence T.
Jakubowski, Ann A.
Papadopoulos, Esperanza B.
Perales, Miguel-Angel http://orcid.org/0000-0002-5910-4571
Rappaport, Theodore S.
Giralt, Sergio A. http://orcid.org/0000-0003-1944-5053
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748)
U.S. Department of Health & Human Services | National Institutes of Health (P01 CA23766, P01 CA23766, P01 CA23766, P01 CA23766, P01 CA23766, P01 CA23766, P01 CA23766, P01 CA23766)
NYU WIRELESS industrial affiliates program, New York, NY, USA
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 10 May 2021
Revised: 6 February 2022
Accepted: 7 February 2022
First Online: 19 February 2022
Competing interests
: CC, MAM, SMD, OA, LTD, AAJ, EBP, and TSR: none. MAP: Reports honoraria from Abbvie, Astellas, Celgene, Bristol-Myers Squibb, Incyte, Karyopharm, Kite/Gilead, Merck, Miltenyi Biotec, MorphoSys, Novartis, Nektar Therapeutics, Omeros, and Takeda. He serves on DSMBs for Cidara Therapeutics, Servier and Medigene and the scientific advisory board of NexImmune. He has received research support for clinical trials from Incyte, Kite/Gilead, Miltenyi Biotec, and Novartis. He serves in a volunteer capacity as a member of the Board of Directors of Be The Match (National Marrow Donor Program, NMDP), as well as on the CIBMTR Cellular Immunotherapy Data Resource (CIDR) Executive Committee. SAG: Reports honoraria and consulting fees from Actinium, Amgen, Celgene, Jazz Scientific, Kite, Novartis, Omeros, and Miltenyi; and research funding from Actinium, Amgen, BMS, Celgene, Janssen, Novartis, Miltenyi, Pfizer, Sanofi, and Takeda. He has served on scientific advisory boards for Actinium, BMS, Celgene, GSK, Jazz Scientific, Janssen, Pfizer, and Sanofi.